RECURRENT HIGH-GRADE GLIOMA
Clinical trials for RECURRENT HIGH-GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HIGH-GRADE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT HIGH-GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer patients get virus injection in new trial
Disease control Recruiting nowThis early-stage study tests a modified herpes virus (MVR-C5252) injected directly into brain tumors in 51 adults with recurrent high-grade glioma. The goal is to see if the virus is safe and can shrink or control the tumor. The trial has multiple stages to find the best dose and…
Matched conditions: RECURRENT HIGH-GRADE GLIOMA
Phase: PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated May 17, 2026 00:45 UTC
-
Immune cells engineered to hunt brain tumors enter first human test
Disease control Recruiting nowThis early-phase study tests a new treatment for adults with glioblastoma or high-grade glioma that has come back after standard therapy. The treatment uses specially engineered natural killer (NK) cells designed to target two different markers on tumor cells at once, which may h…
Matched conditions: RECURRENT HIGH-GRADE GLIOMA
Phase: PHASE1 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New combo aims to fight aggressive brain tumors that have come back
Disease control Recruiting nowThis early-phase study tests a new two-drug combination for adults whose high-grade glioma (a fast-growing brain tumor) has returned after standard treatments. The drugs are temozolomide (given in low, frequent doses) and abexinostat (an experimental pill). The main goal is to fi…
Matched conditions: RECURRENT HIGH-GRADE GLIOMA
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 11, 2026 20:48 UTC